Medical News

RSS

Canberra restaurants put on notice over hygiene

According to health authorities some of the ‘shabbier’ Canberra restaurants have been put on notice after a court quadrupled the fines imposed on an inner north eatery caught preparing food in “Third World” conditions.

9 Sep 2010

56% of Australians won’t vaccinate against Swine flu: Survey

Over fifty per cent of Australians were not vaccinated against the swine flu before winter arrived this year, with many of these people deliberately choosing not to be vaccinated.

9 Sep 2010

Safe sex campaign for over 50’s

New figures have shown an alarming rise in sexually transmitted infections among the over-50s in Britain. Health charity FPA (Flamily Planning Association) has come up with a nation wide campaign using fashion adverts from the 60s and 70s to encourage members of the baby boomer generation to use condoms and practice safe sex.

9 Sep 2010

Obesity key lies in the brain: Study

According to a new international study led in Australia by the Monash Obesity and Diabetes Institute (MODI) at Monash University, high fat diets that lead to obesity and weight gain make the brain immune to signals that tell the body to stop eating and to burn energy.

9 Sep 2010

New melanoma drug in the pipeline from Plexxikon and Roche

Researchers from biotech company Plexxikon have found that their candidate drug for skin cancer melanomas can be administered more effectively in early stages of the disease.

9 Sep 2010

National Dementia Awareness Week

This National Dementia Awareness Week 15-22 September, Alzheimer’s Australia and National Dementia Awareness Week Ambassador, Dr Andrew Rochford will be promoting the benefit of early diagnosis and where worried friends and family can access help.

9 Sep 2010

Microvisk secures £2.5 million to develop world’s first medical diagnostic SmartStrip®

Microvisk Technologies, the developer of a handheld system to monitor the blood clotting status of patients taking the drug Warfarin, has raised £2.5 million through a rights issue to existing investors. The round was significantly oversubscribed and completed within four weeks.

9 Sep 2010

NovaSterilis issued US patent

NovaSterilis Inc. has been issued US Patent # 7,771,652 B2 for “Combined Use of an Alkaline Earth Metal Compound and a Sterilizing Agent to Maintain Osteoinduction Properties of a Demineralized Bone Matrix”

9 Sep 2010

Roche announces Ambry Genetics as first US CSP for NimbleGen SeqCap EZ Exome workflow

Roche NimbleGen announces that Southern California (Aliso Viejo) based genomic services provider Ambry Genetics has officially become a Certified Service Provider (CSP) for the NimbleGen SeqCap EZ Exome workflow. They will provide target-enrichment services using NimbleGen SeqCap EZ Human Exome coupled with next-generation sequencing services for genetic research.

9 Sep 2010

Affinity Health System selects GE Centricity EMR for patient care network

Northeast Wisconsin's nationally recognized Affinity Health System is the latest to choose GE Centricity® EMR for its patient care network. The Catholic, mission-oriented, regional health network is a collaboration between the Fox Valley's Ministry Health Care and Wheaton Franciscan Healthcare and plans to implement Centricity EMR across its 22 multi-specialty clinics in 14 communities to help care for an average of 21,000 patients each year.

9 Sep 2010

3M to acquire Arizant for $810M

3M announced today it has entered into a definitive agreement to acquire Arizant Inc. for a purchase price of $810 million in cash. Based in Eden Prairie, Minn., Arizant is a leading manufacturer of patient warming solutions designed to prevent hypothermia in surgical settings.

9 Sep 2010

Caliper launches toolkit for direct co-registration of images from multiple preclinical imaging modalities

Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery, life sciences research and molecular diagnostics, today introduced software and accessory items to enable the direct co-registration of images from multiple preclinical imaging modalities.

9 Sep 2010

Huifeng Bio-Pharmaceutical Technology to acquire Shangqiu Kexin Rutin Processing

Huifeng Bio-Pharmaceutical Technology, Inc., specializing in developing and producing botanical extracts and other raw materials for pharmaceuticals and food additives, today announces a definitive agreement under which Huifeng will acquire 90% of the equity ownership of Shangqiu Kexin Rutin Processing Ltd., a local leading Rutin manufacturer in Henan Province, at a price of $1.75 million. As a result of the acquisition, Kexin will be a wholly-owned subsidiary of Huifeng.

9 Sep 2010

Researchers discover first compound to activate enzyme telomerase in human body

Sierra Sciences, in collaboration with TA Sciences, Geron Corporation, PhysioAge, and the Spanish National Cancer Research Center (CNIO), has announced the first compound ever discovered that activates the enzyme telomerase in the human body - a critical prerequisite for technology that could arrest or reverse the aging process in humans.

9 Sep 2010

Seaside reports positive data from STX209 Phase 2 study in ASD

Seaside Therapeutics, Inc. announced today positive data from an open-label Phase 2 study of STX209 conducted in patients with autism spectrum disorders (ASD). The primary endpoint of the study, an improvement on the Irritability subscale of the Aberrant Behavior Checklist (ABC-I), achieved statistical significance (p<0.001).

9 Sep 2010

Major contributing factor to maternal age-associated increase in aneuploidy identified

University of Pennsylvania biologists studying human reproduction have identified what is likely the major contributing factor to the maternal age-associated increase in aneuploidy, the term for an abnormal number of chromosomes during reproductive cell division.

9 Sep 2010

Performance Plus Marketing wins IMA's Circle of Excellence Award for Victoza campaign

In today's troubled economy, keeping a sales force motivated to perform can be critical to the success of a business. That's why Novo Nordisk turned to Performance Plus Marketing (PPM) of Roswell, GA, to build an incentive program to support the launch of its Diabetes medication, Victoza(R). The campaign's unprecedented success resulted in the Incentive Marketing Association's Circle of Excellence Award for Best Sales Incentive Program.

9 Sep 2010

Patheon third-quarter total revenues decrease 0.7% to $163.3 million

Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, announced today its results for the third quarter and nine months ended July 31, 2010. Total revenues for the third quarter were $163.3 million or 0.7% lower than the same period last year. Excluding currency fluctuations, current year third quarter revenues would have increased by approximately 3.9% versus the same period last year.

9 Sep 2010

Liquent reveals new solution branding positioning

Liquent Inc., the global leader in regulatory information management solutions and services, revealed today its new solution branding positioning. The announcement comes approximately three months following the merger of the Liquent and Datafarm organizations announced June 1, 2010.

9 Sep 2010

Acceleron Pharma and Shire announce joint development of ACE-031 for DMD

Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, and Shire plc, the global specialty biopharmaceutical company, today announced a joint development and commercialization agreement for ACE-031 and other novel molecules targeting the activin receptor type IIB (ActRIIB) pathway. This pathway plays critical roles in regulating the growth of skeletal muscle.

9 Sep 2010